LINC00470 and central nervous system cancer: Proliferation of glioma cells was strengthened (Fig. 5c–d, P < 0.05) and the number of cells in G1 phase was decreased (Fig. 5e, P < 0.05) in the GBM-exo group and pcDNA3.1-LINC00470 group compared to the Control group.